Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest & Investment Income (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Interest & Investment Income for 5 consecutive years, with $801000.0 as the latest value for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 53.81% year-over-year to $801000.0; the TTM value through Dec 2025 reached $4.4 million, down 47.48%, while the annual FY2025 figure was $4.4 million, 47.48% down from the prior year.
  • Interest & Investment Income hit $801000.0 in Q4 2025 for Kezar Life Sciences, down from $1.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.9 million in Q2 2023 and bottomed at $37000.0 in Q3 2021.
  • Average Interest & Investment Income over 5 years is $1.4 million, with a median of $1.4 million recorded in 2022.
  • Year-over-year, Interest & Investment Income soared 4304.0% in 2022 and then tumbled 53.81% in 2025.
  • Kezar Life Sciences' Interest & Investment Income stood at $50000.0 in 2021, then skyrocketed by 4304.0% to $2.2 million in 2022, then increased by 23.89% to $2.7 million in 2023, then crashed by 36.44% to $1.7 million in 2024, then plummeted by 53.81% to $801000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $801000.0, $1.0 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.